Embryo Transfer: Embryo Expulsion and Outcome
1 other identifier
interventional
134
1 country
1
Brief Summary
According to the studies, about 80% of patients undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) reach to the embryo transfer process, but only a few of them become pregnant. The cause of this difference can be due to some factors such as the endometrial receptivity, quality of transferred embryos and embryo transfer technique. Retained or expelled embryo(s) following embryo transfer is (are) one of the factors which may be effective on outcome. The purpose of this randomized clinical trial study is "Lowering embryo expulsion following embryo transfer to improve outcome."
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 20, 2009
CompletedFirst Posted
Study publicly available on registry
May 21, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedApril 20, 2010
April 1, 2010
1.4 years
May 20, 2009
April 17, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical pregnancy
4-6 weeks
Secondary Outcomes (1)
Implantation rate
6-7 weeks
Study Arms (2)
Control Group
NO INTERVENTIONEmbryo transfer without any intervention
Embryo Expulsion
EXPERIMENTALInterventions
The prevention of embryo expulsion will be carried out after embryo transfer
Eligibility Criteria
You may qualify if:
- Women undergoing IVF or ICSI treatment cycle
- Patients with "long or antagonist" protocol
You may not qualify if:
- The patients with frozen-thawed embryo transfer cycle
- Those with oocyte donation cycle
- The women with uterine abnormality
- The women with submucosal and intramural myoma
- Who does not have good-quality embryos appropriate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royan Institutelead
Study Sites (1)
Royan Institute
Tehran, Tehran Province, Iran
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tahere Madani, MD
Royan Institute
- PRINCIPAL INVESTIGATOR
Mahnaz Ashrafi, MD
Royan Institute
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
May 20, 2009
First Posted
May 21, 2009
Study Start
February 1, 2008
Primary Completion
July 1, 2009
Study Completion
December 1, 2009
Last Updated
April 20, 2010
Record last verified: 2010-04